Michael Kaseta
Fortune : 8 M $ au 31/05/2026
Fortune : 8 M $ au 31/05/2026
Michael Kaseta is currently Director at Bryn Pharma LLC since 2023, Independent Director at Heron Therapeutics, Inc. since 2024, Chief Financial & Operating Officer at Liquidia Corp.
since 2020, and Chief Financial & Operating Officer at Liquidia Technologies, Inc. since 2020.
Former roles include Independent Director at Alimera Sciences, Inc. from 2023 to 2024, Chief Financial Officer-Sanofi North America at Sanofi from 2015 to 2016, Chief Financial Officer at Aerami Therapeutics, Inc. from 2019 to 2020, and Chief Financial & Accounting Officer at Old API Wind-down Ltd. from 2018 to 2019.
Education includes undergraduate studies at James Madison University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0,15% | 23/05/2026 | 130 442 ( 0,15% ) | 8 M $ | 31/05/2026 |
| 14/04/2026 | 29 787 ( 0,02% ) | 25 915 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| LIQUIDIA CORPORATION | Directeur Financier/CFO | 30/11/2020 |
| HERON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/11/2024 |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Directeur/Membre du Conseil | 02/05/2023 |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Directeur Financier/CFO | 20/08/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
| ALIMERA SCIENCES, INC. | Directeur/Membre du Conseil | 16/09/2024 |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Directeur Financier/CFO | 01/11/2020 |
| OLD API WIND-DOWN LTD. | Directeur Financier/CFO | 01/01/2019 |
| SANOFI | Corporate Officer/Principal | 01/09/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Heron Therapeutics, Inc.
Heron Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and commercializes of polymer technologies | Health Technology |
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Alimera Sciences, Inc.
Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Liquidia Technologies, Inc.
Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops particle-based vaccines and therapeutics for prevention and treatment of human disease | Health Technology |
James Madison University
James Madison University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops inhaled insulin products to treat diabetes patients | Health Technology |
Old API Wind-down Ltd.
Old API Wind-down Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Bryn Pharma LLC
Bryn Pharma LLC Medical SpecialtiesHealth Technology Develops bi-dose intranasal devices for patients with anaphylaxis | Health Technology |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national